Tenax Therapeutics, Inc. (TENX)
NASDAQ: TENX · Real-Time Price · USD
5.61
+0.14 (2.56%)
At close: Dec 20, 2024, 4:00 PM
5.59
-0.02 (-0.36%)
After-hours: Dec 20, 2024, 4:44 PM EST
Tenax Therapeutics Stock Forecast
Stock Price Forecast
The 3 analysts with 12-month price forecasts for Tenax Therapeutics stock have an average target of 20.67, with a low estimate of 16 and a high estimate of 30. The average target predicts an increase of 268.45% from the current stock price of 5.61.
Analyst Consensus: Strong Buy
* Price targets were last updated on Oct 24, 2024.
Analyst Ratings
The average analyst rating for TENX stock from 4 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
Rating | Jul '24 | Aug '24 | Sep '24 | Oct '24 | Nov '24 | Dec '24 |
---|---|---|---|---|---|---|
Strong Buy | 1 | 1 | 1 | 2 | 2 | 2 |
Buy | 0 | 0 | 1 | 2 | 2 | 2 |
Hold | 0 | 0 | 0 | 0 | 0 | 0 |
Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
Total | 1 | 1 | 2 | 4 | 4 | 4 |
Latest Forecasts
Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
---|---|---|---|---|---|---|---|
Leerink Partners | Leerink Partners | Buy Initiates $16 | Buy | Initiates | $16 | +185.20% | Oct 24, 2024 |
Guggenheim | Guggenheim | Strong Buy Initiates $16 | Strong Buy | Initiates | $16 | +185.20% | Oct 14, 2024 |
William Blair | William Blair | Buy Initiates n/a | Buy | Initiates | n/a | n/a | Sep 30, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $30 | Strong Buy | Reiterates | $30 | +434.76% | Feb 20, 2024 |
Roth MKM | Roth MKM | Strong Buy Reiterates $480 | Strong Buy | Reiterates | $480 | +8,456.15% | Nov 13, 2023 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-3.36
from -31.04
EPS Next Year
-3.00
from -3.36
Revenue Forecast
Revenue | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | n/a | n/a | n/a | |||
Avg | n/a | n/a | n/a | |||
Low | n/a | n/a | n/a |
Revenue Growth
Revenue Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
EPS Forecast
EPS | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | -0.63 | -0.80 | -0.90 | |||
Avg | -3.36 | -3.00 | -1.91 | |||
Low | -7.20 | -8.12 | -3.83 |
EPS Growth
EPS Growth | 2024 | 2025 | 2026 | 2027 | 2028 | 2029 |
---|---|---|---|---|---|---|
High | - | - | - | |||
Avg | - | - | - | |||
Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.